Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma (Q47733005)

5 February 2018

title

Altered expression and molecular abnormalities of cell-cycle-regulatory proteins in rhabdomyosarcoma (English)

1 reference

5 February 2018

1 reference

Yukiko Takahashi

1

1 reference

5 February 2018

Yoshinao Oda

2

1 reference

5 February 2018

Ken-Ichi Kawaguchi

3

1 reference

5 February 2018

Sadafumi Tamiya

4

1 reference

5 February 2018

Hidetaka Yamamoto

5

1 reference

5 February 2018

Sachiyo Suita

6

1 reference

5 February 2018

Masazumi Tsuneyoshi

7

1 reference

5 February 2018

publication date

1 June 2004

1 reference

5 February 2018

published in

Modern Pathology

1 reference

5 February 2018

volume

17

1 reference

5 February 2018

issue

6

1 reference

5 February 2018

page(s)

660-669

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.3800101

exact match

0 references

cites work

P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

Germline p53 mutations are frequently detected in young children with rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

Immunohistochemical detection of p53 protein in rhabdomyosarcoma: association with clinicopathological features and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

Mechanisms of p53 loss in human sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

High prognostic significance of Mdm2/p53 co-overexpression in soft tissue sarcomas of the extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

Molecular pathogenesis of rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

Evaluation of proliferative index and cell cycle protein expression in choroid plexus tumors in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

Mutation analysis of p53 gene in childhood malignant solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

7 January 2021

Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

7 January 2021

p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

7 January 2021

Expression of the retinoblastoma susceptibility gene in childhood rhabdomyosarcomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

7 January 2021

H-ras and K-ras mutations in soft tissue sarcoma: comparative studies of sarcomas from Korean and American patients

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

7 January 2021

Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

7 January 2021

Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

7 January 2021

Analysis of alterations in the retinoblastoma gene and tumor grade in bone and soft-tissue sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

7 January 2021

Altered expression of the retinoblastoma gene product in human sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

7 January 2021

Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800101

7 January 2021

10.1038/MODPATHOL.3800101

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

15098008

1 reference

5 February 2018